Clinical Drug Investigation

Updated Meta-Analytical Approach to the Efficacy of Antihypertensive Drugs in Reducing Blood Pressure
pp. 735-753(19)
Authors: Baguet, J.P.; Legallicier, B.; Auquier, P.; Robitail, S.

Economic Evaluation of Third-Line Treatment with Alemtuzumab for Chronic Lymphocytic Leukaemia
pp. 755-764(10)
Authors: Scott, W. Guy; Scott, Helen M.

Acceptability of Lansoprazole Orally Disintegrating Tablets in Patients with Gastro-Oesophageal Reflux Disease: ACEPTO Study
pp. 765-770(6)
Authors: de Argila, Carlos Martín; Ponce, Julio; Márquez, Emilio; Plazas, M José; Galván, Jordi; Heras, Joan; Porcel, Joana

A Registry of the Aetiology and Costs of Neuropathic Pain in Pain Clinics: Results of the Registry of aEtiologies and Costs (REC) in Neuropathic Pain Disorders Study
pp. 771-782(12)
Authors: Rodríguez, Manuel J.; García, Antonio J.

BP Goal Achievement in Patients with Uncontrolled Hypertension: Results of the Treat-to-Target Post-Marketing Survey with Irbesartan
pp. 783-796(14)
Authors: Schrader, Joachim; Bramlage, Peter; Lüders, Stephan; Thoenes, Martin; Schirmer, Andreas; Paar, Dieter W.

Effect of Gender on the Tolerability, Safety and Pharmacokinetics of Clazosentan Following Long-Term Infusion
pp. 797-802(6)
Authors: van Giersbergen, Paul L.M.; Dingemanse, Jasper